Schedule 13G ownership disclosure

PHASEBIO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 717224109

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,616,863
Percent of class
6.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000904454-19-000079
Form type
SC 13G
Filer
JOHNSON & JOHNSON
CIK
CIK 200406
Filed
Jan 22, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub